These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15868140)

  • 21. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung disease associated with the IVS8 5T allele of the CFTR gene.
    Noone PG; Pue CA; Zhou Z; Friedman KJ; Wakeling EL; Ganeshananthan M; Simon RH; Silverman LM; Knowles MR
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1919-24. PubMed ID: 11069835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA
    Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation.
    Sheikh SI; Long FR; McCoy KS; Johnson T; Ryan-Wenger NA; Hayes D
    J Cyst Fibros; 2015 Jan; 14(1):84-9. PubMed ID: 25049054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and the cystic fibrosis gender gap.
    Saint-Criq V; Harvey BJ
    Steroids; 2014 Mar; 81():4-8. PubMed ID: 24342234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifier genes in cystic fibrosis lung disease.
    Merlo CA; Boyle MP
    J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macromolecular interactions and ion transport in cystic fibrosis.
    Guggino WB; Banks-Schlegel SP
    Am J Respir Crit Care Med; 2004 Oct; 170(7):815-20. PubMed ID: 15447951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New concepts of pathophysiology and therapy in cystic fibrosis].
    Hirche TO; Loitsch S; Smaczny C; Wagner TO
    Pneumologie; 2005 Nov; 59(11):811-8. PubMed ID: 16385442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physiopathology of cystic fibrosis lung disease].
    Chinet T
    Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifier genetics: cystic fibrosis.
    Cutting GR
    Annu Rev Genomics Hum Genet; 2005; 6():237-60. PubMed ID: 16124861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy.
    Hyde SC; Gill DR; Higgins CF; Trezise AE; MacVinish LJ; Cuthbert AW; Ratcliff R; Evans MJ; Colledge WH
    Nature; 1993 Mar; 362(6417):250-5. PubMed ID: 7681548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic Fibrosis: Microbiology and Host Response.
    Zemanick ET; Hoffman LR
    Pediatr Clin North Am; 2016 Aug; 63(4):617-36. PubMed ID: 27469179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early pulmonary disease in cystic fibrosis.
    Accurso FJ
    Curr Opin Pulm Med; 1997 Nov; 3(6):400-3. PubMed ID: 9391757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of early inflammation and infection in cystic fibrosis: a review of new and potential interventions.
    Weller PH
    Pediatr Pulmonol; 1997 Aug; 24(2):143-5; discussion 159-61. PubMed ID: 9292911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory Cell Therapy to Target Cystic Fibrosis Inflammation.
    Khoury O; Barrios C; Ortega V; Atala A; Murphy SV
    Am J Respir Cell Mol Biol; 2018 Jan; 58(1):12-20. PubMed ID: 28707978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.